Percutaneous Ultrasound-Guided Gastrostomy (PUG) Course - August
August 13, 2022 | Baltimore, MD, United States
American College of Gastroenterology Annual Scientific Meeting & Postgraduate Course (ACG 2022)
October 21-26, 2022 | Charlotte, NC, United States
Interprofessonal Approach to Management of Critically Ill Liver Patients
August 15-16, 2022 | Cleveland, OH, United States
Gastroenterology and Hepatology Symposium: Practice Pearls and Novel Therapies
August 20-21, 2022 | Atlanta, GA, United States
Gastroenterology, Hepatology and Nutrition Update
August 26-27, 2022 | Nashville, TN, United States
2022 ACG IBD School & Midwest Regional Postgraduate Course
August 26-28, 2022 | Indianapolis, IN, United States
Percutaneous Ultrasound-Guided Gastrostomy (PUG) Course - September
September 03, 2022 | Baltimore, MD, United States
International Liver Association 16th Annual Conference (ILCA 2022)
September 01-04, 2022 | Madrid, Spain
Etrolizumab vs. infliximab for moderate to severely active ulcerative colitis treatment (GARDENIA)
The Lancet: Gastroenterology & Hepatology
Intensive versus standard drug therapy for symptomatic Crohn's disease strictures (STRIDENT)
The Lancet: Gastroenterology & Hepatology
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST)
The Lancet: Gastroenterology & Hepatology
AJM300 (carotegrast methyl), an oral alpha4-integrin antagonist, for patients with moderate ulcerative colitis: a phase 3 trial
The Lancet: Gastroenterology & Hepatology
Statin use and reduced hepatocellular carcinoma risk in patients with non- alcoholic fatty liver disease
Clinical Gastroenterology and Hepatology
Guselkumab for the treatment of Crohn disease: Induction results from the phase 2 GALAXI-1 study
Gastroenterology
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)
Diabetes, Obesity and Metabolism
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial
The Lancet: Gastroenterology & Hepatology
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial
The Lancet: Gastroenterology & Hepatology
Rectal indomethacin to prevent pancreatitis after extracorporeal shock wave lithotripsy (RIPEP): A single-center, double-blind, randomized, placebo-controlled trial
The Lancet: Gastroenterology & Hepatology